Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer
Willem Jan van Weelden, Roy Lalisang, Johan Bulten, Kristina Lindemann, Heleen J. van Beekhuizen, Hans Trum, Dorry Boll, Henrica M.J. Werner, Luc R.C.W. van Lonkhuijzen, Refika Yigit, David Forsse, Petronella O. Witteveen, Khadra Galaal, Alexandra van Ginkel, Eliana Bignotti, Vít Weinberger, Sanne Sweegers, Judith R. Kroep, Sílvia Cabrera, Marc P.L.M. Snijders, Márcia A. Inda, Ane Gerda Zahl Eriksson, Camilla Krakstad, Andrea Romano, Anja van de Stolpe, Johanna M.A. Pijnenborg
Topics & Concepts
MedicineHormonal therapyEndometrial cancerEstrogenOncologyInternal medicineEstrogen receptorClinical endpointCancerProgesterone receptorHormoneBreast cancerClinical trialEndometrial and Cervical Cancer TreatmentsEstrogen and related hormone effectsMenopause: Health Impacts and Treatments